EFFETTI DELLA SOMMINISTRAZIONE DI UN B2 AGONISTA E DI UN BECHICO IN ASMATICI ED IN PAZIENTI CON OSTRUZIONE CRONICA DELLE VIE AEREE

Translated title of the contribution: Reproterol and fominoben for bronchial asthma and chronic obstructive lung disease

D. Degl'Innocenti, E. Marchi, F. Gigliotti

Research output: Contribution to journalArticle

Abstract

Changes in forced expiratory volume in 1 sec. (FEV1) induced by the administration of a Beta-2 agonist (Reproterol, 500 mcg MDI) and a bechic (Fominoben 40 mg i.v.) were evaluated both in asthmatics and in patients with chronic obstructive lung disease (COLD). In each patient the administration of the drugs was carried out in the following order: Reproterol (R1) → Fominoben (F) → Reproterol (R2). R1, F, R2 induced significant changes in FEV1 when compared to control values (P1. Only in patients with COLD the FEV1 values measured after R2 were significantly greater than those observed after R1 (P

Translated title of the contributionReproterol and fominoben for bronchial asthma and chronic obstructive lung disease
Original languageItalian
Pages (from-to)271-274
Number of pages4
JournalEuropean Review for Medical and Pharmacological Sciences
Volume6
Issue number2
Publication statusPublished - 1984

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Reproterol and fominoben for bronchial asthma and chronic obstructive lung disease'. Together they form a unique fingerprint.

  • Cite this